AI-powered biomarker platform for remote diagnostics and virtual care
Everlywell operates a digital health platform combining at-home diagnostic testing, AI-driven biomarker analysis, and telehealth integration. The hiring mix is heavily clinical and sales-focused (14 of 23 active roles), not engineering-centric, which reflects a business model built on licensed lab capacity and enterprise partnerships rather than proprietary software scaling. Projects span member engagement optimization, rural health access, and public-sector expansion—signaling a shift from direct-to-consumer toward health-plan and government contract revenue.
Everlywell is a digital health company providing remote diagnostic testing, biomarker intelligence, and integrated virtual care for health plans, employers, and consumers. The platform combines at-home lab collection with AI-powered analysis and telehealth consultation to manage chronic conditions and enable preventive screening. Over a decade, the company has delivered nearly 1 billion health insights to 60 million people and serves 8 of the 10 largest U.S. health plans alongside hundreds of other enterprise partners. Operations include a nationwide clinical network, integrated laboratory, and software platform. The company is headquartered in Austin and employs 201–500 people.
Everlywell uses Salesforce, AWS, PostgreSQL, Python, React, Next.js, and TypeScript for core platform and CRM. Testing is handled via Cypress, Playwright, and Selenium. Observability relies on Datadog and Sentry. Analytics tools include Mixpanel, Amplitude, and Google Analytics.
Everlywell is hiring in the United States and France. The company is headquartered in Austin, Texas.
Everlywell's technology stack, projects, and hiring signals are inferred from public hiring and company data — career pages, public listings, and company web presence — then clustered and de-duplicated. Figures are estimates that refresh over time. Read our full methodology →
This is not an official vendor or customer list. It is a technology-adoption signal inferred from public data, intended for B2B research.